These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

345 related articles for article (PubMed ID: 32829493)

  • 1. Secukinumab may be remedy for systemic amyloidosis findings secondary to hidradenitis suppurativa.
    Tas-Aygar G; Gonul M; Ozcan I; Ayli MD; Ertoy-Baydar D
    Dermatol Ther; 2020 Nov; 33(6):e14205. PubMed ID: 32829493
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Two diseases one remedy? Systemic amyloidosis secondary to hidradenitis suppurativa: Treatment with infliximab.
    Özer İ; Karaçin C; Adışen E; Güz G; Ali Gürer M
    Dermatol Ther; 2017 Mar; 30(2):. PubMed ID: 27862787
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Amyloidosis secondary to hidradenitis suppurativa. Exceptional response to infliximab.
    Montes-Romero JA; Callejas-Rubio JL; Sánchez-Cano D; González-Martínez FJ; Navas-Parejo A; Ortego-Centeno N
    Eur J Intern Med; 2008 Oct; 19(6):e32-3. PubMed ID: 18848164
    [No Abstract]   [Full Text] [Related]  

  • 4. Open-label, investigator-initiated, single-site exploratory trial evaluating secukinumab, an anti-interleukin-17A monoclonal antibody, for patients with moderate-to-severe hidradenitis suppurativa.
    Prussick L; Rothstein B; Joshipura D; Saraiya A; Turkowski Y; Abdat R; Alomran A; Zancanaro P; Kachuk C; Dumont N; Gottlieb AB; Rosmarin D
    Br J Dermatol; 2019 Sep; 181(3):609-611. PubMed ID: 30801662
    [No Abstract]   [Full Text] [Related]  

  • 5. Guselkumab in the treatment of concomitant hidradenitis suppurativa, psoriasis, and Crohn's disease.
    Berman HS; Villa NM; Shi VY; Hsiao JL
    J Dermatolog Treat; 2021 Mar; 32(2):261-263. PubMed ID: 31389737
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hidradenitis suppurativa resulting in systemic amyloid A amyloidosis: a case report and review of the literature.
    Girouard SD; Falk RH; Rennke HG; Merola JF
    Dermatol Online J; 2012 Jan; 18(1):2. PubMed ID: 22301039
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Severe hidradenitis suppurativa complicated by renal AA amyloidosis.
    Utrera-Busquets M; Romero-Maté A; Castaño Á; Alegre L; García-Donoso C; Borbujo J
    Clin Exp Dermatol; 2016 Apr; 41(3):287-9. PubMed ID: 26206410
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An evaluation of secukinumab for the treatment of moderate-to-severe hidradenitis suppurativa.
    Stergianou D; Kanni T; Damoulari C; Giamarellos-Bourboulis EJ
    Expert Opin Biol Ther; 2024 Apr; 24(4):225-232. PubMed ID: 38602836
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Successful treatment of hidradenitis suppurativa with secukinumab in a patient with ankylosing spondylitis and Familial Mediterranean Fever.
    Unal Enginar A; Gundogdu M
    Mod Rheumatol Case Rep; 2022 Jan; 6(1):19-21. PubMed ID: 34508267
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Renal amyloid A amyloidosis as a complication of hidradenitis suppurativa.
    Schandorff KD; Miller IM; Krustrup D; Jemec GB; Marckmann P
    Clin Nephrol; 2016 Jul; 86(1):51-4. PubMed ID: 27340120
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hidradenitis supparativa complicated by penoscrotal lymphedema and renal amyloidosis.
    Rubaian NFB; Al Zamami HF; Almuhaidib SR; Al Breiki SH
    Saudi Med J; 2022 Jul; 43(7):751-754. PubMed ID: 35830985
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Severe hidradenitis suppurativa successfully treated with secukinumab.
    Głowaczewska A; Szepietowski JC; Matusiak Ł
    Dermatol Ther; 2020 Nov; 33(6):e13845. PubMed ID: 32544258
    [No Abstract]   [Full Text] [Related]  

  • 13. Treatment of severe recalcitrant hidradenitis suppurativa with adalimumab.
    Harde V; Mrowietz U
    J Dtsch Dermatol Ges; 2009 Feb; 7(2):139-41. PubMed ID: 19371236
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Novel Regimen of IL-17A Inhibitor Secukinumab for the Remission of Severe Hidradenitis Suppurativa: Case Report.
    Gutierrez E; Issa N; Resnik B
    J Drugs Dermatol; 2022 Dec; 21(12):1358-1360. PubMed ID: 36468954
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Secukinumab in the treatment of hidradenitis suppurativa.
    Snyder CL; Gibson RS; Porter ML; Kimball AB
    Immunotherapy; 2023 Dec; 15(17):1449-1457. PubMed ID: 37840286
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dapsone as an Effective Treatment for Arthritis Secondary to Hidradenitis Suppurativa.
    Timofte I; Smith H
    Bull Hosp Jt Dis (2013); 2021 Jun; 79(2):137-140. PubMed ID: 34081891
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Spectrum of diseases associated with pyoderma gangrenosum and correlation with effectiveness of therapy: New insights on the diagnosis and therapy of comorbid hidradenitis suppurativa.
    Fischer AH; Jourabchi N; Khalifian S; Lazarus GS
    Wound Repair Regen; 2022 May; 30(3):338-344. PubMed ID: 35385180
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Secukinumab for PASS syndrome: A new choice for therapeutic challenge?
    Li M; Xiang H; Liang Y; Xue L; Zhou X; Yang L; Liu H; Yang M; Tang J; Li W
    Dermatol Ther; 2022 Jul; 35(7):e15507. PubMed ID: 35419914
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Systemic AA amyloidosis in hidradenitis suppurativa: Should we be screening?
    Mac Mahon J; Murray G; McCartney Y; Crowther S; Tobin AM; Molloy K
    J Eur Acad Dermatol Venereol; 2023 May; 37(5):e600-e601. PubMed ID: 36463423
    [No Abstract]   [Full Text] [Related]  

  • 20. Case report: Treating a co-existence of hidradenitis suppurativa and psoriasis with different therapeutic approaches.
    Tampouratzi E; Kanni T; Katsantonis J; Douvali T
    F1000Res; 2019; 8():2002. PubMed ID: 33456757
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.